Ruggiero M, Motti M, Meccariello R, Mazzeo F
Nutrients. 2025; 17(5).
PMID: 40077707
PMC: 11902109.
DOI: 10.3390/nu17050837.
Etse K, Harrad M, Etse K, Zaragoza G, Demonceau A, Mouithys-Mickalad A
Molecules. 2025; 30(5).
PMID: 40076345
PMC: 11901561.
DOI: 10.3390/molecules30051122.
Wang J, Shao F, Yu Q, Ye L, Wusiman D, Wu R
Research (Wash D C). 2025; 8:0612.
PMID: 40046513
PMC: 11880593.
DOI: 10.34133/research.0612.
Rahjoo T, Motamedzadeh A, Ferdosi F, Dadgostar E, Aschner M, Mirzaei H
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40045027
DOI: 10.1007/s00210-025-03861-1.
Li Z, Wang Q, Liu Y, Yang S, Zhao J, Wu C
Front Immunol. 2025; 16:1540998.
PMID: 40028316
PMC: 11868298.
DOI: 10.3389/fimmu.2025.1540998.
The Prognostic Value of Tumor-Associated Neutrophils in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Jiang M, Zhang R, Huang M, Yang J, Liu Q, Zhao Z
Cancer Med. 2025; 14(5):e70614.
PMID: 40013340
PMC: 11865885.
DOI: 10.1002/cam4.70614.
Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors.
Li Y, Yu Y, Lv K, Ge R, Xie X
Front Immunol. 2025; 16:1557726.
PMID: 40013137
PMC: 11861556.
DOI: 10.3389/fimmu.2025.1557726.
Inflammation in cancer: therapeutic opportunities from new insights.
Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q
Mol Cancer. 2025; 24(1):51.
PMID: 39994787
PMC: 11849313.
DOI: 10.1186/s12943-025-02243-8.
Skincare Benefits of a Postbiotic Ferment Produced Through Djon Djon Mushroom Fermentation by Saccharomyces.
Pu C, Shi D, Ingrassia M, Gedeon H, Chu T, Zhang J
J Cosmet Dermatol. 2025; 24(2):e70067.
PMID: 39968713
PMC: 11836922.
DOI: 10.1111/jocd.70067.
Prognostic Impact of Stimulator of Interferon Genes Expression in Triple Negative Breast Cancer.
Maeda T, Ono M, Osako T, Chiba T, Baba S, Iesato A
Cancer Med. 2025; 14(4):e70666.
PMID: 39967410
PMC: 11836529.
DOI: 10.1002/cam4.70666.
[Predictive Value of Prognostic Nutritional Index in Prognosis and
Spontaneous Pleurodesis of Patients with Advanced Non-small Cell Lung Cancer
and Malignant Pleural Effusion].
Tan S, Li W, Tian P
Zhongguo Fei Ai Za Zhi. 2025; 27(12):931-939.
PMID: 39962848
PMC: 11843482.
DOI: 10.3779/j.issn.1009-3419.2024.106.33.
Novel insights into the impact of liver inflammatory responses on primary liver cancer development.
Ait-Ahmed Y, Lafdil F
Liver Res. 2025; 7(1):26-34.
PMID: 39959704
PMC: 11791919.
DOI: 10.1016/j.livres.2023.01.001.
Significance of non-steroidal anti-inflammatory drugs in the prevention and treatment of cervical cancer.
Kan X, Zhou Z, Liu L, Aiskikaer R, Zou Y
Heliyon. 2025; 11(3):e42055.
PMID: 39916829
PMC: 11800076.
DOI: 10.1016/j.heliyon.2025.e42055.
Serum NLR combined with CA125 and HE4 improves the diagnostic and prognostic efficiency in patients with ovarian cancer.
Tian Y, Li X, Zhang H, Wang Y, Li H, Qin Q
Front Oncol. 2025; 14:1494051.
PMID: 39882448
PMC: 11776095.
DOI: 10.3389/fonc.2024.1494051.
Recombinant VSVs: A Promising Tool for Virotherapy.
Vorona K, Moroz V, Gasanov N, Karabelsky A
Acta Naturae. 2025; 16(4):4-14.
PMID: 39877014
PMC: 11771844.
DOI: 10.32607/actanaturae.27501.
Baseline [F]FDG PET/CT radiomics for predicting interim efficacy in follicular lymphoma treated with first-line R-CHOP.
Wen Z, Gao X, Wu Q, Yang J, Sun J, Wu K
BMC Cancer. 2025; 25(1):128.
PMID: 39849387
PMC: 11756111.
DOI: 10.1186/s12885-025-13507-3.
Chemokine family significance and prognostic value in colorectal cancer.
Ding Y, Chen Y, Xie S, Qiu Q, Guo X, Feng Y
Front Immunol. 2025; 15():1404768.
PMID: 39835121
PMC: 11743568.
DOI: 10.3389/fimmu.2024.1404768.
Alpha-Lipoic Acid-Mediated Inhibition of LTB Synthesis Suppresses Epithelial-Mesenchymal Transition, Modulating Functional and Tumorigenic Capacities in Non-Small Cell Lung Cancer A549 Cells.
Torres M, Rios J, Valle A, Indo S, Gv K, Lopez-Moncada F
Curr Ther Res Clin Exp. 2025; 102():100765.
PMID: 39816494
PMC: 11731977.
DOI: 10.1016/j.curtheres.2024.100765.
HALP Score in Predicting Response to Treatment in Patients with Early-Stage Gastric Cancer: A Multi-Centred Retrospective Cohort Study.
Koseci T, Seyyar M, Aydinalp Camadan Y, Celik H, Mete B, Demirhindi H
Medicina (Kaunas). 2025; 60(12.
PMID: 39768966
PMC: 11678702.
DOI: 10.3390/medicina60122087.
The Intersection of Psoriasis and Neoplasia: Risk Factors, Therapeutic Approaches, and Management Strategies.
Mateescu L, Savu A, Mutu C, Vaida C, Serban E, Bucur S
Cancers (Basel). 2025; 16(24.
PMID: 39766123
PMC: 11674284.
DOI: 10.3390/cancers16244224.